← Live StudiesRegistry: recruitingPhase 3

CagriSema switching study in type 2 diabetes

Looks at safety and tolerability when adults with type 2 diabetes switch from semaglutide injections to investigational CagriSema. Everyone in the study receives CagriSema.

Who it's for

  • Age 18+
  • Type 2 diabetes
  • Currently on relevant semaglutide treatment
  • Study team determines fit

Full eligibility rules apply. The study team decides who can take part.

Where it runs

13 research locations in Arizona, California, Hawaii and Utah.

Arizona

  • Gilbert Center For Family MedicineGilbert, AZ

California

  • Ark Clinical ResearchFountain Valley, CA
  • Thrive Clinical Research GroupGlendora, CA
  • Scripps Whittier Diabetes InstLa Jolla, CA
  • Downtown LA Res Ctr. Inc.Los Angeles, CA
  • Valley Clinical Trials, Inc.Northridge, CA
  • Dream Team Clinical ResearchPomona, CA
  • Clinical Trials Research - SacramentoSacramento, CA
  • Linda Vista Health Care CtrSan Diego, CA

Hawaii

  • East West Med Res InstHonolulu, HI

Utah

  • J.Lewis Research IncSalt Lake City, UT
  • Diabetes & Endo Treatment SpecSandy City, UTNot yet recruiting
  • Chrysalis Clinical ResearchSt. George, UT

Site recruitment may change. The official record lists every location, including outside these states.

Interested in this study?

Ask us about it, or refer a patient. Taking part is voluntary, and the study team decides who can join.